US Dollar vs Yen

登録して無料でリアルタイムの株価、インタラクティブチャート、ライブオプションフローなどを入手してください。

登録

ホーム
投資
株式
アメリカ
NYSE
Eli Lilly and Co (LLY)
Eli Lilly and Co (LLY) ニュース

LLY

Eli Lilly (LLY)

Eli Lilly and Co

から:

Regulatory News

Text Search:

次の項目別のソート:

Non-Regulatory News

Showing the most relevant articles for your search:NYSE:LLY

1 2 3 4 5 6 7 8 9 10 次へ >>

日付	受信時刻	ニュースソース	見出し	コード	企業名
2024/06/19	05 : 23	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NYSE:LLY	Eli Lilly and Co
2024/06/19	05 : 22	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NYSE:LLY	Eli Lilly and Co
2024/06/19	05 : 20	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NYSE:LLY	Eli Lilly and Co
2024/06/19	05 : 19	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NYSE:LLY	Eli Lilly and Co
2024/06/19	05 : 17	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NYSE:LLY	Eli Lilly and Co
2024/06/19	05 : 00	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NYSE:LLY	Eli Lilly and Co
2024/06/18	05 : 00	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NYSE:LLY	Eli Lilly and Co
2024/06/15	03 : 49	Edgar (US Regulatory)	Form 144 - Report of proposed sale of securities	NYSE:LLY	Eli Lilly and Co
2024/06/12	05 : 00	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NYSE:LLY	Eli Lilly and Co
2024/06/11	20 : 11	IH Market News	FDA Panel Supports Eli Lilly’s Donanemab, Rio Tinto Expands Stake in Boyne Smelters, and More News	NYSE:LLY	Eli Lilly and Co
2024/06/11	05 : 00	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NYSE:LLY	Eli Lilly and Co
2024/06/08	22 : 03	PR Newswire (US)	Lilly's tirzepatide was superior to placebo for MASH resolution, and more than half of patients achieved improvement in fibrosis at 52 weeks	NYSE:LLY	Eli Lilly and Co
2024/06/08	05 : 00	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NYSE:LLY	Eli Lilly and Co
2024/06/08	03 : 03	Edgar (US Regulatory)	Form 144 - Report of proposed sale of securities	NYSE:LLY	Eli Lilly and Co
2024/06/07	05 : 00	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NYSE:LLY	Eli Lilly and Co
2024/06/06	03 : 23	Edgar (US Regulatory)	Form 144 - Report of proposed sale of securities	NYSE:LLY	Eli Lilly and Co
2024/06/05	20 : 48	Edgar (US Regulatory)	Form 8-K - Current report	NYSE:LLY	Eli Lilly and Co
2024/06/05	20 : 45	PR Newswire (US)	Lilly announces departure of Anat Ashkenazi, chief financial officer	NYSE:LLY	Eli Lilly and Co
2024/06/05	05 : 14	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NYSE:LLY	Eli Lilly and Co
2024/06/05	05 : 00	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NYSE:LLY	Eli Lilly and Co
2024/06/04	22 : 00	PR Newswire (US)	Melissa Seymour to join Lilly as executive vice president of Global Quality	NYSE:LLY	Eli Lilly and Co
2024/06/04	07 : 30	Edgar (US Regulatory)	Form 144 - Report of proposed sale of securities	NYSE:LLY	Eli Lilly and Co
2024/06/04	07 : 29	Edgar (US Regulatory)	Form 144 - Report of proposed sale of securities	NYSE:LLY	Eli Lilly and Co
2024/06/04	05 : 15	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NYSE:LLY	Eli Lilly and Co
2024/06/04	05 : 14	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NYSE:LLY	Eli Lilly and Co
2024/06/04	05 : 00	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NYSE:LLY	Eli Lilly and Co
2024/06/01	21 : 00	PR Newswire (US)	Updated Data from the Phase 1/2 Study of Olomorasib in KRAS G12C-Mutant Advanced Solid Tumors Presented at the 2024 ASCO® Annual Meeting	NYSE:LLY	Eli Lilly and Co
2024/06/01	03 : 32	Edgar (US Regulatory)	Form 144 - Report of proposed sale of securities	NYSE:LLY	Eli Lilly and Co
2024/05/31	05 : 00	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NYSE:LLY	Eli Lilly and Co
2024/05/30	05 : 00	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NYSE:LLY	Eli Lilly and Co

Showing the most relevant articles for your search:NYSE:LLY

1 2 3 4 5 6 7 8 9 10 次へ >>

BNP Paribas (QX)

Financial Select Sector

US Dollar vs Sterling

Gold vs US Dollar

Delayed Upgrade Clock

顧客サポート: +44 (0) 203 8794 460 | support@advfn.com

ADVFNのサービスをご利用いただくには、利用規約